Burosumab

Definition: Burosumab, sold under the brand name Crysvita, is a human monoclonal antibody medication approved 2018 for the treatment of X-linked hypophosphatemia and tumor-induced osteomalacia. source: Wikipedia

ID

772032008

ID date

6 Sep 2021

Previous ID

35576411000001101

Name

Burosumab